Compare Stocks: AVNS, SNAL, ICUI, and NVST

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVNS Avanos Medical	$24.99	$24.96	$9.30 ▼ $25.49	$1.17B	1.57	700,357 shs	N/A
ICUI ICU Medical	$187.69 +2.1%	$158.29	$112.50 ▼ $192.85	$4.69B	0.74	294,030 shs	80,978 shs
NVST Envista	$28.02 +0.7%	$26.72	$18.77 ▼ $30.42	$4.52B	0.86	2.96 million shs	1.25 million shs
SNAL Snail	$2.98 -1.1%	$3.87	$1.70 ▼ $10.80	$25.53M	1.29	1.84 million shs	44,728 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVNS Avanos Medical	0.00%	0.00%	+0.06%	+0.99%	+122.33%
ICUI ICU Medical	+0.68%	+0.92%	+16.67%	+42.11%	+49.45%
NVST Envista	+0.37%	-2.64%	+3.96%	+17.06%	+33.92%
SNAL Snail	-2.27%	-34.42%	-39.07%	-46.25%	-38.88%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVNS Avanos Medical	$24.99	$24.96	$9.30 ▼ $25.49	$1.17B	1.57	700,357 shs	N/A
ICUI ICU Medical	$187.69 +2.1%	$158.29	$112.50 ▼ $192.85	$4.69B	0.74	294,030 shs	80,978 shs
NVST Envista	$28.02 +0.7%	$26.72	$18.77 ▼ $30.42	$4.52B	0.86	2.96 million shs	1.25 million shs
SNAL Snail	$2.98 -1.1%	$3.87	$1.70 ▼ $10.80	$25.53M	1.29	1.84 million shs	44,728 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVNS Avanos Medical	0.00%	0.00%	+0.06%	+0.99%	+122.33%
ICUI ICU Medical	+0.68%	+0.92%	+16.67%	+42.11%	+49.45%
NVST Envista	+0.37%	-2.64%	+3.96%	+17.06%	+33.92%
SNAL Snail	-2.27%	-34.42%	-39.07%	-46.25%	-38.88%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVNS Avanos Medical	1.50	Reduce	N/A	N/A
ICUI ICU Medical	2.89	Moderate Buy	$192.80	4.92% Upside
NVST Envista	2.50	Moderate Buy	$29.31	5.49% Upside
SNAL Snail	2.00	Hold	N/A	N/A

Current Analyst Ratings Breakdown

Latest AVNS, SNAL, ICUI, and NVST Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/14/2026	SNAL Snail	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D) ➝ Sell (D-)
8/7/2026	ICUI ICU Medical	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$170.00 ➝ $200.00
8/7/2026	ICUI ICU Medical	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Strong-Buy	$200.00
8/7/2026	ICUI ICU Medical	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$163.00 ➝ $195.00
8/7/2026	ICUI ICU Medical	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$165.00 ➝ $187.00
8/7/2026	NVST Envista	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/7/2026	SNAL Snail	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/6/2026	NVST Envista	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
8/6/2026	NVST Envista	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$23.00
8/6/2026	NVST Envista	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$34.00
8/6/2026	NVST Envista	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$29.00

(Data available from 8/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVNS Avanos Medical	$715.90M	1.64	$3.42 per share	7.30	$16.73 per share	1.49
ICUI ICU Medical	$2.16B	2.13	$14.64 per share	12.55	$86.03 per share	2.14
NVST Envista	$2.72B	1.64	$2.15 per share	12.93	$18.89 per share	1.47
SNAL Snail	$85.90M	0.30	N/A	N/A	($2.90) per share	-1.04

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVNS Avanos Medical	-$72.90M	-$1.61	N/A	26.59	N/A	-10.39%	5.39%	3.97%	N/A
ICUI ICU Medical	$730K	$1.18	155.73	23.62	2.56	1.39%	7.91%	4.17%	11/5/2026 (Estimated)
NVST Envista	$47M	$0.58	47.90	16.94	1.34	3.33%	7.88%	4.33%	11/4/2026 (Estimated)
SNAL Snail	-$27.24M	-$1.26	N/A	1.92	N/A	-8.83%	-15.49%	-13.52%	N/A

Latest AVNS, SNAL, ICUI, and NVST Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/11/2026	Q2 2026	SNAL Snail	$1.55	-$0.36	-$1.91	-$0.36	$29.00 million	$21.80 million
8/6/2026	Q2 2026	ICUI ICU Medical	$1.91	$2.37	+$0.46	$0.76	$533.44 million	$547.88 million
8/5/2026	Q2 2026	NVST Envista	$0.3353	$0.41	+$0.0747	$0.33	$716.11 million	$730.50 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVNS Avanos Medical	N/A	N/A	N/A	N/A	N/A
ICUI ICU Medical	N/A	N/A	N/A	N/A	N/A
NVST Envista	N/A	N/A	N/A	N/A	N/A
SNAL Snail	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVNS Avanos Medical	0.11	2.48	1.40
ICUI ICU Medical	0.56	2.43	1.21
NVST Envista	0.47	2.43	2.07
SNAL Snail	N/A	0.55	0.55

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVNS Avanos Medical	95.17%
ICUI ICU Medical	96.10%
NVST Envista	N/A
SNAL Snail	0.36%

Insider Ownership

Company	Insider Ownership
AVNS Avanos Medical	2.33%
ICUI ICU Medical	2.10%
NVST Envista	0.99%
SNAL Snail	66.78%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVNS Avanos Medical	2,287	46.85 million	45.76 million	Optionable
ICUI ICU Medical	13,000	24.99 million	24.47 million	Optionable
NVST Envista	12,000	160.62 million	159.03 million	Optionable
SNAL Snail	60	8.52 million	2.83 million	Not Optionable

AVNS, SNAL, ICUI, and NVST Headlines

Recent News About These Companies

In the 1990s, a predatory flatworm was released in Samoa to control giant African snails; it later became linked to the decline and extinction of native island snails

August 18 at 5:41 PM | timesofindia.indiatimes.com

Snail slime does many jobs thanks to calcium

August 18 at 2:38 AM | sciencenews.orgS

Snail Stock Tumbles 38% in a Month: Buy the Dip, Hold or Sell?

August 17 at 12:56 PM | zacks.com

A snail in the tropics can fire a harpoon loaded with venom strong enough to kill a person

August 16 at 2:32 AM | msn.com

Noble Financial Predicts Snail's Q3 Earnings (NASDAQ:SNAL)

August 16 at 1:13 AM | americanbankingnews.com

Mollusks from another mother, here’s the lowdown on Alaska snails and slugs

August 15, 2026 | adn.comA

Snail Games 重點介紹遊戲產品組合中的多項里程碑

August 15, 2026 | globenewswire.com

Snail (NASDAQ:SNAL) Stock Rating Lowered by Wall Street Zen

August 15, 2026 | americanbankingnews.com

Snail Games reports progress on indie titles, sets PixARK expansion date

August 14, 2026 | proactiveinvestors.com

Snail, Inc. Highlights Indie and ARK Portfolio Milestones, Announces PixARK: Terracrypt Release Date

August 14, 2026 | quiverquant.comQ

Snail Games Highlights Multiple Milestones Across Gaming Portfolio

August 14, 2026 | globenewswire.com

Snail Bookings Decline 20%: Is Consumer Demand Losing Steam?

August 14, 2026 | zacks.com

A cone snail’s harpoon delivers a venom with no known antidote

August 13, 2026 | msn.com

Noble says Snail's AAA pipeline and AI push point to upside ahead

August 12, 2026 | proactiveinvestors.com

Snail outlines Q3 2026 recognition of approximately $11M of deferred revenue as July ARK DLC launches shift into second half

August 11, 2026 | seekingalpha.com

Snail, Inc. (SNAL) Q2 2026 Earnings Call Transcript

August 11, 2026 | seekingalpha.com

Snail, Inc. (SNAL) Reports Q2 Loss, Misses Revenue Estimates

August 11, 2026 | zacks.com

Snail, Inc. Signs New SaltyTV Service Agreements

August 11, 2026 | tipranks.com

Snail sees strong second-half setup as ARK content pipeline and new AAA titles advance

August 11, 2026 | proactiveinvestors.com

Snail, Inc. Reports Second Quarter 2026 Financial Results

August 11, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS, SNAL, ICUI, and NVST Company Descriptions

Avanos Medical NYSE:AVNS

$24.99 0.00 (0.00%)

As of 08/18/2026

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

ICU Medical NASDAQ:ICUI

$187.69 +3.93 (+2.14%)

As of 11:40 AM Eastern

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Envista NYSE:NVST

$28.02 +0.20 (+0.71%)

As of 11:40 AM Eastern

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Snail NASDAQ:SNAL

$2.98 -0.03 (-1.10%)

As of 11:37 AM Eastern

Snail, Inc., together with its subsidiaries, researches, develops, markets, publishes, and distributes interactive digital entertainment for consumers worldwide. It offers games, content, and support for various platforms, including game consoles, personal computers, mobile phones, and tablets. Snail, Inc. was founded in 2009 and is headquartered in Culver City, California. Snail, Inc. operates as a subsidiary of Olive Wood Global Development Limited.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AVNS, SNAL, ICUI, and NVST Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AVNS, SNAL, ICUI, and NVST Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AVNS, SNAL, ICUI, and NVST Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS, SNAL, ICUI, and NVST Company Descriptions

Avanos Medical NYSE:AVNS

ICU Medical NASDAQ:ICUI

Envista NYSE:NVST

Snail NASDAQ:SNAL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AVNS, SNAL, ICUI, and NVST Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AVNS, SNAL, ICUI, and NVST Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AVNS, SNAL, ICUI, and NVST Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS, SNAL, ICUI, and NVST Company Descriptions

Avanos Medical NYSE:AVNS

ICU Medical NASDAQ:ICUI

Envista NYSE:NVST

Snail NASDAQ:SNAL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools